Akme Fintrade to Raise ₹85.75 Crore Via Preferential Warrants

Akme Fintrade is set to raise ₹85.75 crore by issuing 12.25 crore warrants, signaling a significant capital infusion for its expansion plans.

Reader Takeaway: Capital infusion for expansion; shareholder vote & warrant conversion are key.

What just happened (today’s filing)

Akme Fintrade (India) Limited's Board of Directors has approved a preferential issue of up to 12.25 crore warrants, each convertible into one equity share at ₹7 per warrant. This move is projected to raise approximately ₹85.75 crore for the non-banking financial company (NBFC).

The primary objectives for this capital infusion are to meet working capital requirements and fund business expansion initiatives.

The warrants are convertible into equity shares within 18 months of their allotment. Before this can proceed, shareholder approval is required at an Extra-Ordinary General Meeting (EGM) scheduled for March 20, 2026.

Shareholders can participate in the decision-making process through remote e-voting, which will be open from March 17 to March 19, 2026. The cut-off date for determining voting eligibility is March 13, 2026.

Why this matters

For an NBFC like Akme Fintrade, access to capital is crucial for growth. This preferential issue will bolster its balance sheet, enabling it to lend more and potentially expand its product offerings and geographical reach.

It signifies the company's intent to grow its assets under management and meet increasing credit demand, particularly in the rural and semi-urban segments it serves.

The backstory (grounded)

Established in 1996, Akme Fintrade is an Udaipur-based NBFC that has built its business model around providing secured lending to salaried individuals and small business owners, often in underserved areas. Its core products include vehicle finance and MSME loans.

The company recently underwent its Initial Public Offering (IPO) in June 2024, raising about ₹132 crore. This event added to its equity base and provided additional capital. Akme Fintrade has also utilized Non-Convertible Debentures (NCDs) for fundraising, with recent approvals for issuances totalling over ₹230 crore.

In recent months, there has been notable activity regarding shareholding, with an acquirer group led by Subhash Phootarmal Rathod consistently increasing its stake, reaching 6.783% by February 2026. The company has also faced some regulatory attention, with insider trading and SAST filings noted in September 2025.

What changes now

• Strengthened Capital Base: The ₹85.75 crore infusion will significantly enhance Akme Fintrade's capital adequacy, providing a buffer for future lending.
• Enhanced Growth Potential: The funds are designated for working capital and expansion, allowing the company to scale its operations and potentially enter new markets or product segments.
• Capital Structure Impact: The conversion of warrants into equity shares will eventually increase the company's total equity and potentially alter the shareholding pattern.
• Future Dilution Risk: If warrants are exercised, existing shareholders will face dilution, a factor to consider for investment decisions.

Risks to watch

• Warrant Conversion Failure: If warrant holders do not exercise their conversion option within the 18-month period, the upfront payment may be forfeited, and the expected capital infusion will not materialize.
• Execution Risk: The successful deployment of raised funds for working capital and business expansion is contingent on effective management and strategic execution.
• Financial Stability: Reports suggest Akme Fintrade's financial stability may be less robust compared to larger peers, with a lower Altman Z score.
• Geographic Concentration: A significant portion of the company's Assets Under Management (AUM) is concentrated in Rajasthan.
• Slow Sales Growth: Historically, the company has experienced slow sales growth over the past five years.

Peer comparison

Akme Fintrade operates in a competitive NBFC landscape alongside giants like Bajaj Finance and Shriram Finance, which boast market capitalizations in lakhs of crores. In contrast, Akme Fintrade's market cap is in the hundreds of crores.

Many NBFCs are actively raising capital, driven by regulatory requirements like the RBI's listing deadline and the expectation of robust credit demand across sectors like MSMEs and retail. While leading players often tap international debt markets via ECBs or dollar bonds, smaller entities like Akme Fintrade typically opt for domestic equity or debt instruments.

Context metrics (time-bound)

• As of March 2025, Akme Fintrade's net sales stood at approximately ₹98.58 crore, with a profit after tax of around ₹33.23 crore.
• For the quarter ending December 2025, the company reported a net profit of approximately ₹10.39 crore.
• As of February 24, 2026, Akme Fintrade's market capitalization was around ₹307 crore, with a Price to Earnings (PE) ratio of 8.18 and a book value per share of ₹9.42.
• Its Assets Under Management (AUM) were over ₹523 crore as of February 24, 2026.

What to track next

• EGM Outcome: The primary trigger is the shareholder vote on March 20, 2026. Approval is essential for the warrant issue to proceed.
• Warrant Allotment: If approved, the details of the warrant allotment to various investors will be crucial.
• Fund Utilization: Monitor how effectively the ₹85.75 crore is deployed towards working capital and planned business expansion.
• Shareholding Pattern: Track changes in the shareholding pattern post-warrant conversion, including potential dilution.
• Financial Performance: Future quarterly results will indicate the impact of the capital infusion on profitability and growth metrics.
• Acquirer Group Activity: Keep an eye on further stake building by the existing acquirer group led by Subhash Phootarmal Rathod.